Početna › Akutna mijeloična leukemija
Kliničke studije za Akutna mijeloična leukemija koje traže sudionike u SAD-u
276 studija za Akutna mijeloična leukemija traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Houston, TX85 studija
- New York City, NY51 studija
- Boston, MA44 studija
- Baldwin Park, CA40 studija
- Seattle, WA40 studija
- Columbus, OH35 studija
- Philadelphia, PA34 studija
- Durham, NC33 studija
- Atlanta, GA30 studija
- Tampa, FL29 studija
- Chicago, IL26 studija
- Portland, OR25 studija
- Miami, FL24 studija
- Washington, DC24 studija
- Los Angeles, CA24 studija
- St. Louis, MO22 studija
- Dallas, TX21 studija
- Nashville, TN21 studija
- Birmingham, AL21 studija
- Queens, NY21 studija
- Cincinnati, OH20 studija
- Cleveland, OH20 studija
- Edison, NJ20 studija
- Minneapolis, MN20 studija
- Buffalo, NY19 studija
- Mountain View, CA19 studija
- Baltimore, MD19 studija
- Pittsburgh, PA18 studija
- Winston-Salem, NC18 studija
- Greenburgh, NY18 studija
- Salt Lake City, UT17 studija
- Ann Arbor, MI17 studija
- New Haven, CT17 studija
- Milwaukee, WI17 studija
- Rochester, NY16 studija
- Charlotte, NC16 studija
- Aurora, CO16 studija
- Cedar Rapids, IA16 studija
- Charlottesville, VA16 studija
- Madison, WI16 studija
Po državama
- Alabama21 studija
- Arizona22 studija
- Arkansas13 studija
- Colorado22 studija
- Connecticut17 studija
- Delaware7 studija
- Distrikt Columbia10 studija
- Florida55 studija
- Georgia38 studija
- Havaji7 studija
- Idaho9 studija
- Illinois31 studija
- Indiana14 studija
- Iowa17 studija
- Kalifornija79 studija
- Kansas20 studija
- Kentucky14 studija
- Louisiana13 studija
- Maine9 studija
- Maryland31 studija
- Massachusetts45 studija
- Michigan24 studija
- Minnesota27 studija
- Mississippi8 studija
- Missouri23 studija
- Montana6 studija
- Nebraska10 studija
- Nevada9 studija
- New Hampshire9 studija
- New Jersey32 studija
- New Mexico9 studija
- New York71 studija
- North Carolina43 studija
- North Dakota4 studija
- Ohio57 studija
- Oklahoma14 studija
- Oregon27 studija
- Pennsylvania45 studija
- Rhode Island11 studija
- South Carolina16 studija
- South Dakota6 studija
- Tennessee31 studija
- Texas94 studija
- Utah17 studija
- Vermont7 studija
- Virginia24 studija
- Washington41 studija
- West Virginia6 studija
- Wisconsin25 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07581002Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
U tijeku regrutacijaFaza 2
Od 60 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07437950Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07304011Assessment of Geriatric Evaluations Impact on New AML Guidance
U tijeku regrutacijaOpažajna studija
Od 50 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT05909501Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
U tijeku regrutacijaFaza 1
Od 18 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06904066Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07723703Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06484062Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
U tijeku regrutacijaOpažajna studija
Od 0 do 38 godina · Oba spola · Ažurirano 1. lis 2026. · NCT06131801A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
U tijeku regrutacijaFaza 1
Od 12 do 78 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT03802695A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT06763341Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
U tijeku regrutacijaFaza 2
Od 18 do 59 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT05554393A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05564390Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT03629171A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06548230Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07211958Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT03874052Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
U tijeku regrutacijaRana faza 1
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT03661307Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06871410A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 12 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT05360160A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
U tijeku regrutacijaFaza 1
Do 21 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07012044Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT06317649A Study of CRD3874-SI in People With Leukemia
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07661095Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.